India Therapeutic Drug Monitoring Market By Product (Consumables, Equipment), By Technology (Immunoassays, Chromatography-Ms and Others), By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others), By End User (Hospital, Private Labs), By Region, Competition, Forecast & Opportunities, FY 2026
India therapeutic drug monitoring market is forecast to grow from an estimated $ 85 million in FY 2021 to $ 119 million by FY 2026 owing to the rising need of maintaining the drug levels in blood for prevention of diseases. Therapeutic drug monitoring is the practice of monitoring drug levels in the blood and maintaining them to an optimum level with the motive of preventing diseases, eradicating toxicity and many other health-related issues.
India therapeutic drug monitoring market has been gaining traction over years due to the increase in Indian population, especially the old age population. Precision medicines have been taking over normal medicines over the last few years, which has also led to the growth of the market. Furthermore, increasing government funding and novel product launches have fueled the market growth. However, scarcity of competent skillset is expected to hamper the market growth over the course of next five years.
India therapeutic drug monitoring market is segmented into product, technology, class of drug, end user, and region. The technology segment is further divided into immunoassays, chromatography-ms and others, out of which, immunoassays segment is expected to dominate the market in FY2021 as it is a precise method and gives more specific results compared to other technologies. Another driving factor of the segment is that it requires minimal maintenance and skills for operation.
The major players operating in India therapeutic drug monitoring market are Roche Diagnostics India Pvt Ltd, Abbott India Limited, bioMйrieux India, Bio-Rad laboratories India Pvt.Ltd, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers India, Randox Laboratories (India) Private Limited, Sekisui Chemical India Private Limited, amongst others.
Years considered for this report:
Historical Years: FY2016 - FY2019
TechSci Research calculated the market size of India therapeutic drug monitoring market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Report Scope:
In this report, India therapeutic drug monitoring market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in India therapeutic drug monitoring market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
India therapeutic drug monitoring market has been gaining traction over years due to the increase in Indian population, especially the old age population. Precision medicines have been taking over normal medicines over the last few years, which has also led to the growth of the market. Furthermore, increasing government funding and novel product launches have fueled the market growth. However, scarcity of competent skillset is expected to hamper the market growth over the course of next five years.
India therapeutic drug monitoring market is segmented into product, technology, class of drug, end user, and region. The technology segment is further divided into immunoassays, chromatography-ms and others, out of which, immunoassays segment is expected to dominate the market in FY2021 as it is a precise method and gives more specific results compared to other technologies. Another driving factor of the segment is that it requires minimal maintenance and skills for operation.
The major players operating in India therapeutic drug monitoring market are Roche Diagnostics India Pvt Ltd, Abbott India Limited, bioMйrieux India, Bio-Rad laboratories India Pvt.Ltd, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers India, Randox Laboratories (India) Private Limited, Sekisui Chemical India Private Limited, amongst others.
Years considered for this report:
Historical Years: FY2016 - FY2019
- Base Year: FY2020
- Estimated Year: FY2021
- Forecast Period: FY2022 - FY2026
- To analyze and estimate the market size of India therapeutic drug monitoring market from FY2016 to FY2019.
- To estimate and forecast the market size of India therapeutic drug monitoring market from FY2020 to FY2026.
- To classify and forecast India therapeutic drug monitoring market based on product, technology, class of drug, end user, region and company.
- To identify dominant region or segment in the India therapeutic drug monitoring market.
- To identify drivers and challenges for India therapeutic drug monitoring market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India therapeutic drug monitoring market.
- To conduct pricing analysis for India therapeutic drug monitoring market.
- To identify and analyze the profile of leading players operating in India therapeutic drug monitoring market.
- To identify key sustainable strategies adopted by market players in India therapeutic drug monitoring market.
TechSci Research calculated the market size of India therapeutic drug monitoring market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- End users, hospitals, laboratories and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to therapeutic drug monitoring
- Market research and consulting firms
Report Scope:
In this report, India therapeutic drug monitoring market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Market, By Product:
- Consumables
- Equipment
- Market, By Technology:
- Immunoassays
- Chromatography-Ms
- Others
- Market, By Class of Drug:
- Antiepileptic Drugs
- Antiarrhythmic Drugs
- Immunosuppressant Drugs
- Antibiotic Drugs
- Others
- Market, By End User:
- Hospital
- Private Labs
- Market, By Region:
- North
- East
- West
- South
Company Profiles: Detailed analysis of the major companies present in India therapeutic drug monitoring market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON INDIA THERAPEUTIC DRUG MONITORING MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMERS
6. INDIA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables, Equipment)
6.2.2. By Technology (Immunoassays, Chromatography-Ms and Others)
6.2.3. By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others)
6.2.4. By End User (Hospital, Private Labs)
6.2.5. By Region (North, East, West, South)
6.2.6. By Company (FY2020)
6.3. Market Attractiveness Index
7. IMMUNOASSAYS INDIA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Market (Colorimetric Immunoassays, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radio Immunoassays, and others)
7.2.2. By Product
7.2.3. By Class of Drug
7.2.4. By End User
8. CHROMATOGRAPHY-MS INDIA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Liquid Chromatography-Mass Spectrometry, Gas Chromatography-Mass Spectrometry)
8.2.2. By Product
8.2.3. By Class of Drug
8.2.4. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. IMPORT-EXPORT ANALYSIS
13. INDIA ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Roche Diagnostics India Pvt Ltd
14.2.2. Abbott India Limited
14.2.3. bioMйrieux India Pvt. Ltd.
14.2.4. Bio-Rad laboratories India Pvt.Ltd
14.2.5. Thermo Fisher Scientific Inc.
14.2.6. Danaher Corporation
14.2.7. Siemens Healthineers India Pvt. Ltd
14.2.8. Randox Laboratories (India) Private Limited
14.2.9. Sekisui Chemical India Private Limited
15. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON INDIA THERAPEUTIC DRUG MONITORING MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMERS
6. INDIA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables, Equipment)
6.2.2. By Technology (Immunoassays, Chromatography-Ms and Others)
6.2.3. By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others)
6.2.4. By End User (Hospital, Private Labs)
6.2.5. By Region (North, East, West, South)
6.2.6. By Company (FY2020)
6.3. Market Attractiveness Index
7. IMMUNOASSAYS INDIA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Market (Colorimetric Immunoassays, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radio Immunoassays, and others)
7.2.2. By Product
7.2.3. By Class of Drug
7.2.4. By End User
8. CHROMATOGRAPHY-MS INDIA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Liquid Chromatography-Mass Spectrometry, Gas Chromatography-Mass Spectrometry)
8.2.2. By Product
8.2.3. By Class of Drug
8.2.4. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. IMPORT-EXPORT ANALYSIS
13. INDIA ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Roche Diagnostics India Pvt Ltd
14.2.2. Abbott India Limited
14.2.3. bioMйrieux India Pvt. Ltd.
14.2.4. Bio-Rad laboratories India Pvt.Ltd
14.2.5. Thermo Fisher Scientific Inc.
14.2.6. Danaher Corporation
14.2.7. Siemens Healthineers India Pvt. Ltd
14.2.8. Randox Laboratories (India) Private Limited
14.2.9. Sekisui Chemical India Private Limited
15. STRATEGIC RECOMMENDATIONS
LIST OF FIGURES
Figure 1: India Therapeutic Drug Monitoring Market Size, By Value (USD Million), FY2016-FY2026
Figure 2: India Therapeutic Drug Monitoring Market Share, By Product, FY2016-FY2026
Figure 3: India Therapeutic Drug Monitoring Market Size, By Technology, FY2016-FY2026
Figure 4: India Therapeutic Drug Monitoring Market Size, By Immunoassays, FY2016-FY2026
Figure 5: India Therapeutic Drug Monitoring Market Share, By Chromatography-Ms, FY2016-FY2026
Figure 6: India Therapeutic Drug Monitoring Market Share, By Class of Drug, FY2016-FY2026
Figure 7: India Therapeutic Drug Monitoring Market Share, By End-User, FY2016-FY2026
Figure 8: India Therapeutic Drug Monitoring Market Share, By Company, FY2016-FY2026
Figure 9: India Therapeutic Drug Monitoring Market Share, By Region, FY2016-FY2026
Figure 10: India Therapeutic Drug Monitoring Market Share Attractiveness Index, By Technology, By Value, 2015-2025F
COMPANIES MENTIONED
1.Roche Diagnostics India Pvt Ltd
2.Abbott India Limited
3.bioMйrieux India Pvt. Ltd.
4.Bio-Rad laboratories India Pvt.Ltd
5.Thermo Fisher Scientific Inc.
6.Danaher Corporation
7.Siemens Healthineers India Pvt. Ltd
8.Randox Laboratories (India) Private Limited
9.Sekisui Chemical India Private Limited
Figure 1: India Therapeutic Drug Monitoring Market Size, By Value (USD Million), FY2016-FY2026
Figure 2: India Therapeutic Drug Monitoring Market Share, By Product, FY2016-FY2026
Figure 3: India Therapeutic Drug Monitoring Market Size, By Technology, FY2016-FY2026
Figure 4: India Therapeutic Drug Monitoring Market Size, By Immunoassays, FY2016-FY2026
Figure 5: India Therapeutic Drug Monitoring Market Share, By Chromatography-Ms, FY2016-FY2026
Figure 6: India Therapeutic Drug Monitoring Market Share, By Class of Drug, FY2016-FY2026
Figure 7: India Therapeutic Drug Monitoring Market Share, By End-User, FY2016-FY2026
Figure 8: India Therapeutic Drug Monitoring Market Share, By Company, FY2016-FY2026
Figure 9: India Therapeutic Drug Monitoring Market Share, By Region, FY2016-FY2026
Figure 10: India Therapeutic Drug Monitoring Market Share Attractiveness Index, By Technology, By Value, 2015-2025F
COMPANIES MENTIONED
1.Roche Diagnostics India Pvt Ltd
2.Abbott India Limited
3.bioMйrieux India Pvt. Ltd.
4.Bio-Rad laboratories India Pvt.Ltd
5.Thermo Fisher Scientific Inc.
6.Danaher Corporation
7.Siemens Healthineers India Pvt. Ltd
8.Randox Laboratories (India) Private Limited
9.Sekisui Chemical India Private Limited